Migraine headaches affect thousands of Americans and millions worldwide. There are several medications that are being prescribed for migraines and for many these do not work well. In a couple of ...

Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in patients with nonopioid chronic migraine (CM) and MOH, according to a ...

There are already plans for the potentially life-changing treatment to be approved by the Food and Drug Administration in May. Senior Editor, Science Could a monthly injection halve the number of ...

In a review, researchers outlined the safety and efficacy of erenumab, the only monoclonal antibody built to interact with the calcitonin gene related peptide (CGRP) receptor rather than the CGRP ...

People who have tried unsuccessfully to prevent migraine with other treatments may find relief with a new drug, according to a preliminary study released Tuesday. Erenumab is part of new class of ...

Erenumab treatment has been associated with reductions in migraine frequency and improvements in health-related quality of life that were maintained for at least 5 years, according to the results of ...

A trial of a new monthly injection, called erenumab, found the drug can significantly reduce the frequency of migraines for regular sufferers and lesson their impact when they do strike. “Our study ...

SAN FRANCISCO — The fully humanized monoclonal antibody erenumab (Aimovig, Novartis/Amgen) is safe and effective in preventing refractory episodic migraine, new research suggests. Results of a ...

The experimental drug erenumab (AMG 334, Amgen and Novartis) is effective and safe in patients with episodic migraine in whom previous treatments have failed, results of a new phase 3b trial have ...

About The Study: In this study, monthly, 140 mg erenumab injections safely and effectively achieved medication overuse headaches remission in patients with nonopioid chronic migraine and medication ...